Tourmaline Bio, Inc. (TRML)
TRML Stock Price Chart
Explore Tourmaline Bio, Inc. interactive price chart. Choose custom timeframes to analyze TRML price movements and trends.
TRML Company Profile
Discover essential business fundamentals and corporate details for Tourmaline Bio, Inc. (TRML) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 May 2021
Employees
74.00
Website
https://www.tourmalinebio.comCEO
Sandeep C. Kulkarni
Description
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
TRML Financial Timeline
Browse a chronological timeline of Tourmaline Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Apr 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.96.
Earnings released on 13 Aug 2025
EPS came in at -$0.90 surpassing the estimated -$0.94 by +4.26%.
Earnings released on 2 May 2025
EPS came in at -$0.89 surpassing the estimated -$0.91 by +2.20%.
Earnings released on 13 Mar 2025
EPS came in at -$0.86 surpassing the estimated -$0.91 by +5.49%, while revenue for the quarter reached $40.00K .
Earnings released on 7 Nov 2024
EPS came in at -$0.78 surpassing the estimated -$0.84 by +7.14%.
Earnings released on 8 Aug 2024
EPS came in at -$0.68 surpassing the estimated -$0.72 by +5.56%.
Earnings released on 13 May 2024
EPS came in at -$0.55 surpassing the estimated -$0.68 by +19.12%.
Earnings released on 19 Mar 2024
EPS came in at -$0.81 falling short of the estimated -$0.75 by -8.00%, while revenue for the quarter reached $2.28M .
Earnings released on 14 Nov 2023
EPS came in at -$1.64 falling short of the estimated -$0.94 by -74.47%.
Dividend declared on 20 Oct 2023
A dividend of $1.51 per share was announced, adjusted to $15.12. The dividend was paid on 20 Oct 2023.
Stock split effective on 20 Oct 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2023
EPS came in at -$0.20 surpassing the estimated -$2.00 by +90.00%.
Earnings released on 31 Mar 2023
EPS came in at -$0.37 surpassing the estimated -$3.87 by +90.46%.
Earnings released on 31 Dec 2022
EPS came in at -$0.00 .
Earnings released on 30 Sept 2022
EPS came in at -$0.00 surpassing the estimated -$4.54 by +100.00%.
Earnings released on 30 Jun 2022
EPS came in at -$0.00 surpassing the estimated -$4.55 by +99.97%.
Earnings released on 31 Mar 2022
EPS came in at -$0.00 .
Earnings released on 30 Dec 2021
EPS came in at -$3.48 .
Earnings released on 29 Sept 2021
EPS came in at -$3.18 .
Earnings released on 30 Jun 2021
EPS came in at -$4.15 .
Earnings released on 31 Mar 2021
EPS came in at -$2.43 .
Earnings released on 31 Dec 2020
EPS came in at -$9.60 .
Earnings released on 30 Sept 2020
EPS came in at -$9.40 .
TRML Stock Performance
Access detailed TRML performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.